The risk of immune thrombocytopenic purpura after vaccination in children and adolescents

Pediatrics

Volumn 129, Issue 2, 2012, Pages 248-255

  O'Leary, Sean T ^a,b   Glanz, Jason M ^b   McClure, David L ^b   Akhtar, Aysha ^c   Daley, Matthew F ^a,b   Nakasato, Cynthia ^b   Baxter, Roger ^b   Davis, Robert L ^b   Izurieta, Hector S ^c   Lieu, Tracy A ^d,e   Ball, Robert ^c  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b KAISER PERMANENTE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adverse reactions; Children; Immune thrombocytopenia purpura; Thrombocytopenia; Vaccines

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCAL CONJUGATE VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; TRIVALENT INFLUENZA VACCINE; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; EARLY CHILDHOOD INTERVENTION; EXPOSURE; FEMALE; GROUPS BY AGE; HEALTH CARE ORGANIZATION; HEMATOCHEZIA; HEMATURIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; THROMBOCYTE COUNT; VACCINATION REACTION;

ADOLESCENT; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEPATITIS A VACCINES; HUMANS; INFANT; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RISK; UNITED STATES; VACCINATION;

EID: 84856538613     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1111     Document Type: Article

References (43)

1. Fisher OD, Kraszewski TM. Thrombocytopenic purpura following measles. Arch Dis Child. 1952;27(132):144-146
2. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med. 1966;275(7):352-356
3. Autret E, Jonville-Béra AP, Galy-Eyraud C, Hessel L. Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella [in French]. Therapie. 1996;51(6):677-680 (Pubitemid 27107827)
4. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J. 1996;15(1):88-90 (Pubitemid 26029252)
5. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003;55(1):107-111 (Pubitemid 36110846)
6. France EK, Glanz J, Xu S, et al Vaccine Safety Datalink Team. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121(3). Available at: www.pediatrics.org/cgi/content/ full/121/3/e687
7. Jonville-Béra AP, Autret E, Galy-Eyraud C, Hessel L. Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and Pasteur- Mérieux Sérums et Vaccins. Pediatr Infect Dis J. 1996;15(1):44-48
8. Kiefaber RW. Thrombocytopenic purpura after measles vaccination. N Engl J Med. 1981;305(4):225 (Pubitemid 11040745)
9. Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measlesmumps- rubella vaccination: a systematic review of the literature and guidance for management. J Pediatr. 2010;156(4):623-628
10. Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001;84(3):227-229 (Pubitemid 32250829)
11. Nieminen U, Peltola H, Syrjälä MT, Mäkipernaa A, Kekomäki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr. 1993;82(3):267-270 (Pubitemid 23107545)
12. Hudson JB, Weinstein L, Chang TW. Thrombocytopenic purpura in measles. J Pediatr. 1956;48(1):48-56
13. Morse EE, Zinkham WH, Jackson DP. Thrombocytopenic purpura following rubella infection in children and adults. Arch Intern Med. 1966;117(4):573-579
14. Ozsoylu S, Kanra G, Savas G. Thrombocytopenic purpura related to rubella infection. Pediatrics. 1978;62(4):567-569 (Pubitemid 8399440)
15. Polat A, Inan M, Cakaloz I, Karakus YT. A case of symptomatic idiopathic thrombocytopenic purpura during mumps. Pediatr Hematol Oncol. 2005;22(3):215-218 (Pubitemid 40604865)
16. Rand M. Virus associated idiopathic thrombocytopenic purpura. Transfus Sci. 1998;19 (3):253-259
17. Yeager A. Varicella associated thrombocytopenia: clues to the etiology of childhood idiopathic thrombocytopenic purpura. Johns Hopkins Med J. 1980;146:270-274
18. Yenicesu I, Yetgin S, Ozyürek E, Aslan D. Virus-associated immune thrombocytopenic purpura in childhood. Pediatr Hematol Oncol. 2002;19(6):433-437 (Pubitemid 34924923)
19. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Hematol Oncol Clin North Am. 2010;24(1):249-273
20. Arya LS, Ghai OP, Saraya AK. Thrombocytopenic purpura following DPT vaccination. Pediatr Hematol Oncol. 1993;10(4):381-383 (Pubitemid 23333825)
21. Neau D, Bonnet F, Michaud M, et al. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis. 1998;30(2):115-118 (Pubitemid 28389065)
22. Polat A, Akca H, Dagdeviren E. Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey. Vaccine. 2008;26 (51):6495-6496
23. Poullin P, Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet. 1994;344(8932):1293 (Pubitemid 24334691)
24. Ronchi F, Cecchi P, Falcioni F, et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child. 1998;78(3):273-274 (Pubitemid 28176345)
25. Sakha K, Malekian A, Aslandabadi S. Hepatitis B vaccination and infantile idiopathic thrombocytopenic purpura. Med J Islam World Acad Sci. 2005;15(4):149-151
26. Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25(suppl 1):S47-S51 (Pubitemid 37517919)
27. Butros L. M.D., Bussel, J., M.D. Intracranial Hemorrhage in Immune Thrombocytopenic Purpura: A Retrospective Analysis. J Pediatr Hematol Oncol. 2003;25(8):661-664
28. Krivit W, Tate D, White JG, Robison LL. Idiopathic thrombocytopenic purpura and intracranial hemorrhage. Pediatrics. 1981;67 (4):570-571 (Pubitemid 11061337)
29. Woerner S, Abildgaard C, French BN. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics. 1981;67(4):453-460 (Pubitemid 11061312)
30. Jadavji T, Scheifele D, Halperin S; Canadian Paediatric Society/Health Cananda Immunization Monitoring Program. Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J. 2003;22(2):119-122 (Pubitemid 36228127)
31. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Pediatr Clin North Am. 2008;55(2):393-420, ix (Pubitemid 351442783)
32. Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008;121(3). Available at: www.pediatrics.org/ cgi/content/full/121/3/e506
33. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-2393
34. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345(8949):567-569
35. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768-1797
36. Glanz JM, McClure DL, Xu S, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59(8):808-818 (Pubitemid 43996937)
37. Naus J, Wallenstein S. Temporal surveillance using scan statistics. Stat Med. 2006; 25(2):311-324 (Pubitemid 43141509)
38. Klein NP, Fireman B, Yih WK, et al Vaccine Safety Datalink. Measles-mumps-rubellavaricella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1). Available at: www.pediatrics.org/cgi/content/ full/126/1/e1
39. Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol. 2010;149(6):855-864
40. Bernheim M, Mouriquand C, Germain D, Gilly R, Nicolas A. 2 cases of prolonged thrombopenic purpura following an antidiphtheriaantitetanus vaccination. Splenectomy. Cure [in French]. Pediatrie. 1960;15:433-438
41. Sauvé LJ, Scheifele D. Do childhood vaccines cause thrombocytopenia? Paediatr Child Health (Oxford). 2009;14(1):31-32
42. Woo EJ, Wise RP, Menschik D, et al. Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008. Vaccine. 2011;29(6):1319-1323
43. Bergmann AK, Grace RF, Neufeld EJ. Genetic studies in pediatric ITP: outlook, feasibility, and requirements. Ann Hematol. 2010;89 (suppl 1):S95-S103